Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07540143 · ClinicalTrials.gov registry record · NA
The REACH-OUT Trial
A NA study, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
NCT07540143: Recruiting NA study, sponsored by Northwestern University.
NCT07540143 is a NA study that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07540143, a NA study, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
Study Summary
Test the effectiveness of a technology-enabled strategy to optimize blood pressure among reproductive-aged women with hypertension receiving care in Federally Qualified Health Centers.
Primary Outcome
Blood pressure (BP) will be measured three times at baseline and 3 months. Participants will be seated and rested for 5 minutes before measurement. The mean of the 2nd and 3rd readings will be used for analysis. Measurements will follow standard research procedures regarding arm selection, and patient positioning. Remote guidance via Zoom will be provided as needed to ensure proper technique.
Interventions
- OTHER Patient navigator support
- OTHER Health literacy-informed patient education materials
- BEHAVIORAL BP monitor, brief orientation, and portal tools
- OTHER The MeDS assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2026-06-16 |
| Est. Completion | 2030-06-30 |
| Phase | NA |
What NCT07540143 shows while recruiting
NCT07540143 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 4 interventions - of which Patient navigator support is the first listed.
NCT07540143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07540143 about?
NCT07540143 is a clinical study titled "The REACH-OUT Trial". Test the effectiveness of a technology-enabled strategy to optimize blood pressure among reproductive-aged women with hypertension receiving care in Federally Qualified Health Centers.
What is the current status of trial NCT07540143?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2026-06-16. Estimated completion is 2030-06-30.
What interventions are being tested in trial NCT07540143?
The interventions under investigation include: Patient navigator support (OTHER), Health literacy-informed patient education materials (OTHER), BP monitor, brief orientation, and portal tools (BEHAVIORAL), The MeDS assessment (OTHER).
Who is sponsoring clinical trial NCT07540143?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07540143's enrollment target sits among peer trials
350 292nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI